Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?

Ann Surg Oncol. 2024 May;31(5):3062-3068. doi: 10.1245/s10434-024-14939-0. Epub 2024 Jan 28.

Abstract

Background: Distinguishing malignant from benign causes of obstruction at the liver hilum can pose a diagnostic dilemma. This study aimed to determine factors that predict benign causes of hilar obstruction and long-term outcomes after resection.

Methods: Consecutive patients who underwent surgery for hilar obstruction at a single institution between 1997 and 2022 were retrospectively analyzed. Median follow-up was 26 months (range 0-281 months).

Results: Among 182 patients who underwent surgery for hilar obstruction, 25 (14%) patients were found to have benign disease. Median CA19-9 level after normalization of serum bilirubin was 80 U/mL (range 1-5779) and 21 U/mL (range 1-681) among patients with malignant and benign strictures, respectively (p = 0.001). Cross-sectional imaging features associated with malignancy were lobar atrophy, soft tissue mass/infiltration, and vascular involvement (all p < 0.05). Factors not correlated with malignancy were jaundice upon presentation, peak serum bilirubin, sex, and race. Preoperative bile duct brushing or biopsy had sensitivity and specificity rates of 82% and 55%, respectively. Among patients who underwent resection with curative intent, grade 3-4 complications occurred in 55% and 29% of patients with malignant and benign strictures, respectively (p = 0.028). Postoperative long-term complications of chronic portal hypertension and recurrent cholangitis occurred in ≥ 10% of patients with both benign and malignant disease (p = non-significant).

Conclusions: Strictures at the liver hilum continue to present diagnostic and management challenges. Postoperative complications and long-term sequelae of portal hypertension and recurrent cholangitis develop in a significant number of patients after resection of both benign and malignant strictures.

Keywords: Biliary stricture; Cholangitis; Hilar obstruction; Malignant masquerade; Perihilar cholangiocarcinoma; Portal hypertension.

MeSH terms

  • Bile Duct Neoplasms* / surgery
  • Bilirubin
  • Cholangiocarcinoma* / surgery
  • Cholangitis*
  • Constriction, Pathologic / surgery
  • Humans
  • Hypertension, Portal*
  • Neoplasms*
  • Retrospective Studies

Substances

  • Bilirubin